These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7210773)

  • 21. [Action of injected disopyramide on ventricular arrhythmias and atrioventricular conduction].
    Vogel M; Desoutter P; Bellanger P; Motté G; Welti JJ
    Arch Mal Coeur Vaiss; 1976 Apr; 69(4):395-406. PubMed ID: 59581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spontaneous variability of premature ventricular complexes and its significance in assessing anti-arrhythmic drug efficacy.
    Dai CZ; Zhang YL; Zeng B; Lu YX
    Chin Med J (Engl); 1989 Apr; 102(4):273-7. PubMed ID: 2477200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1978 May; 15(5):331-68. PubMed ID: 350555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antiarrhythmic effect of disopyramid retard versus propranolol retard in ventricular extrasystole].
    Fechter P; Nager F
    Schweiz Med Wochenschr; 1982 Dec; 112(51):1897-900. PubMed ID: 6187065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Circadian variations in the frequency of arrhythmia and quantitative analysis of rhythm disturbances].
    Steinbach K; Eder A; Glogar D; Joskowicz G; Weber H
    Acta Med Austriaca; 1978; 5(4-5):132-4. PubMed ID: 91299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy and tolerability of sustained-release disopyramide in the treatment of cardiac arrhythmia. Results of a study with 593 patients].
    Lekieffre J; Vaur L; Kacet S; Lacroix D
    Ann Cardiol Angeiol (Paris); 1993 Feb; 42(2):115-9. PubMed ID: 8494319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Preventive disopyramide in patients with ventricular arrhythmias detected by exercise].
    Cardonne A; Pérez-Medina T; García-Barreto D
    Arch Inst Cardiol Mex; 1976; 46(1):69-73. PubMed ID: 779692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method].
    Schwartz PJ; Facchini M; Bonazzi O; Cuspidi C; Priori S; Varisco T; Zuanetti G
    G Ital Cardiol; 1985 Mar; 15(3):273-82. PubMed ID: 4018465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population pharmacokinetics, protein binding and antiarrhythmic effects of disopyramide enantiomers in arrhythmic patients.
    Aso R; Ohashi K; Katoh T; Ogata H
    Int J Clin Pharmacol Res; 2001; 21(3-4):137-46. PubMed ID: 12067143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of early cardiovascular involvement in patients with systemic sclerosis].
    Wranicz JK; Strzondała M; Zielińska M; Cygankiewicz I; Ruta J; Dziankowska-Bartkowiak B; Sysa-Jedrzejowska A
    Przegl Lek; 2000; 57(7-8):389-92. PubMed ID: 11109311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Intravenously disopyramide phosphate administration for treatment of arrhythmias].
    Aquaro G; Belli R; Pavia M; Rey L; Ravera A; Possavino G; Idone P
    G Ital Cardiol; 1982; 12(7):509-19. PubMed ID: 7169147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Variability of arrhythmias and symptoms--their effect on long-term ECG analysis].
    Weber H; Schmidinger H; Norman G; Rimpfl T; Wolfram J
    Wien Med Wochenschr; 1988 Jan; 138(1-2):12-8. PubMed ID: 3354219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiarrhythmic effectiveness of creatinol O-phosphate in man.
    Cadel A; Palumbo A; Zerilli G; Pria R; Fanciulli R; Conversano S; Galbiati R
    Arzneimittelforschung; 1979; 29(9a):1485-7. PubMed ID: 94266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Nocturnal ventricular arrhythmia in patients with sleep apnea and suspected coronary heart disease].
    Koehler U; Glaremin T; Cassel W; Feuring M; Pomykaj T; Schäfer H; Stellwaag M
    Med Klin (Munich); 1993 Dec; 88(12):684-90. PubMed ID: 7510360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scatterplots of RR and RT interval variability bring evidence for diverse non-linear dynamics of heart rate and ventricular repolarization duration in coronary heart disease.
    Sosnowski M; Czyz Z; Tendera M
    Europace; 2001 Jan; 3(1):39-45. PubMed ID: 11271949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heart rate variability in patients suffering from structural heart disease and decreased AV-nodal conduction capacity. Insights into the formation of heart rate variability.
    Schwab JO; Eichner G; Schmitt H; Schrickel J; Yang A; Balta O; Lüderitz B; Lewalter T
    Z Kardiol; 2004 Mar; 93(3):229-33. PubMed ID: 15024591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics of hemodynamic and electrocardiographic changes following intravenous disopyramide.
    Hulting J; Rosenhamer G
    Acta Med Scand; 1979; 205(5):417-23. PubMed ID: 443082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and electrophysiological observations with disopyramide in drug-resistant and recurrent symptomatic arrhythmias.
    Myers JB; Millar RN; Obel IW
    S Afr Med J; 1978 Dec; 54(26):1083-9. PubMed ID: 746466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Computer assisted long-term ECG analysis: method and clinical importance (author's transl)].
    Weber H; Joskowicz G; Glogar D; Steinbach K
    Acta Med Austriaca; 1982; 9(2):78-83. PubMed ID: 7080792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pro-arrhythmic effects of amiodarone and concomitant rate-control medication.
    Schrickel JW; Schwab JO; Yang A; Bielik H; Bitzen A; Lüderitz B; Lewalter T
    Europace; 2006 Jun; 8(6):403-7. PubMed ID: 16687421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.